Texas · J0875

Injection, Dalbavancin, 5 Mg in Texas

Texas Medicare Avg
$11.67
0% below national avg
National Medicare Avg
$11.68
All states combined
Billed Charge (TX)
$40.63
What providers submit
Est. Commercial (TX)
$33.70
National avg: $32.86
Est. Cash / Self-Pay (TX)
$22.16
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

359.7K
Services in TX
82
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Texas

Provider Medicare Services
Wolcott, Joseph M.D. $11.65 54.6K
Nagra, Shehzadi MD $11.78 33.5K
Graff, Jeremiah DPM $11.61 27.2K
Desai, Vipul MD $11.47 24.7K
Hidalgo, Jesus M.D. $11.62 19.8K
Palau, Leonardo MD $11.77 19.2K
Baharloo, Babak $11.79 18.6K
Youree, Bryan MD $11.76 12.5K
Mcdonald, Cheryl M.D. $11.73 12.3K
Amaro, Justin D.O. $11.83 11.3K
Spak, Cedric MD $11.72 11.1K
Dixon, Amanda FNP-C $11.75 8.8K
Aly, Sarfraz MD $10.98 8.5K
Price, Todd M.D. $11.46 8.4K
Kamana, Mallika MD $11.00 6.3K
Issa, Husam MD $11.86 6.0K
Venghaus, Brad M.D. $11.78 5.4K
Nyalakonda, Harita M.D. $11.73 5.1K
Onorato, Michelle MD $11.72 3.8K

Texas Pricing in Context

In Texas, CPT code J0875 (Injection, Dalbavancin, 5 Mg) carries an average Medicare payment of $11.67 — 0% below the national benchmark of $11.68. 82 providers across the state submitted claims for this procedure in 2023, performing 359.7K total services. Individual payments in TX ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Texas is $40.63, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Texas sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Drugs (Administered) procedures, the estimated commercial insurance price in Texas lands near $33.70, with self-pay cash prices typically around $22.16. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Injection, Dalbavancin, 5 Mg cost in Texas?

The average Medicare payment for Injection, Dalbavancin, 5 Mg in Texas is $11.67, which is 0% below the national average of $11.68. Providers in TX typically bill $40.63 for this procedure.

What does Injection, Dalbavancin, 5 Mg cost with insurance in Texas?

With commercial insurance in Texas, Injection, Dalbavancin, 5 Mg costs an estimated $33.70. Without insurance, the estimated cash price is $22.16. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Injection, Dalbavancin, 5 Mg in Texas?

82 providers in Texas billed Medicare for Injection, Dalbavancin, 5 Mg in 2023, performing 359.7K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Injection, Dalbavancin, 5 Mg cheaper in Texas than the national average?

Yes — Injection, Dalbavancin, 5 Mg costs 0% below the national average in Texas. The state average Medicare payment is $11.67 compared to $11.68 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial